Evolutionary Therapy for Rhabdomyosarcoma
Condition:   Rhabdomyosarcoma Interventions:   Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Vinorelbine;   Drug: Actinomycin D;   Drug: Cyclophosphamide Pill Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Pediatric Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2020 Category: Research Source Type: clinical trials